Lead Plaintiff Deadline: April 11, 2023
Please Upload related files below
Fill in below.
Looking for more?
(a) common stock pursuant and/or traceable to documents issued in connection with the Company’s initial public offering conducted on or about July 23, 2021; and/or (b) securities between July 23, 2021, and December 9, 2022, both dates inclusive
(i) the treatment effect of the Company’s product candidate, CB-010, was not as durable as defendants had led investors to believe; (ii) accordingly, CB-010’s clinical and commercial prospects were overstated; and (iii) as a result, documents issued in connection with Caribou’s initial public offer and defendants’ public statements throughout the class period were materially false and/or misleading and failed to state information required to be stated therein.
In order to be included in the lawsuit, you must have incurred a loss on shares of Caribou, either: A) purchased or acquired during the class period listed above, if applicable; or B) pursuant to the Initial Public Offering (IPO) of Caribou, if applicable.
If you suffered a loss in Caribou during the relevant time frame, or pursuant to Caribou’s IPO if listed above, you have until April 11, 2023 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.